Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NEOPRISM-CRC Trial - Neoadjuvant Pembro Stratified to TMB for High-Risk Stage 2 or 3 dMMR/MSI-High CRC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Kai-Keen Shiu
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Kai-Keen Shiu
88 views
June 12, 2024
Comments 0
Login to view comments.
Click here to Login